These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 31745330)
21. The drug-resistant bacteria that pose the greatest health threats. Willyard C Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092 [No Abstract] [Full Text] [Related]
22. Coping with antibiotic resistance: the impending crisis. Gould IM Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626 [TBL] [Abstract][Full Text] [Related]
23. Platforms for antibiotic discovery. Lewis K Nat Rev Drug Discov; 2013 May; 12(5):371-87. PubMed ID: 23629505 [TBL] [Abstract][Full Text] [Related]
25. Report calls for $2bn global fund to kickstart antibiotic development. Wise J BMJ; 2015 May; 350():h2635. PubMed ID: 25975228 [No Abstract] [Full Text] [Related]
26. Priority pathogens and the antibiotic pipeline: an update. Beyer P; Paulin S Bull World Health Organ; 2020 Mar; 98(3):151. PubMed ID: 32132745 [No Abstract] [Full Text] [Related]
27. A three-step plan for antibiotics. Nature; 2014 May; 509(7502):533. PubMed ID: 24877183 [No Abstract] [Full Text] [Related]
28. Antibiotic Pipeline Coordinators. Baraldi E; Lindahl O; Savic M; Findlay D; Årdal C J Law Med Ethics; 2018 Jun; 46(1_suppl):25-31. PubMed ID: 30146958 [TBL] [Abstract][Full Text] [Related]
29. Policy: An intergovernmental panel on antimicrobial resistance. Woolhouse M; Farrar J Nature; 2014 May; 509(7502):555-7. PubMed ID: 24877180 [No Abstract] [Full Text] [Related]
30. Questions about the 10 x '20 Initiative. Outterson K; Powers JH; Gould IM; Kesselheim AS Clin Infect Dis; 2010 Sep; 51(6):751-2; author reply 754-5. PubMed ID: 20731566 [No Abstract] [Full Text] [Related]
31. Antimicrobial resistance: no action today, no cure tomorrow. Sharma A Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100 [No Abstract] [Full Text] [Related]
35. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria. Fernandes P; Pizza M Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177 [No Abstract] [Full Text] [Related]
36. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Penesyan A; Gillings M; Paulsen IT Molecules; 2015 Mar; 20(4):5286-98. PubMed ID: 25812150 [TBL] [Abstract][Full Text] [Related]
37. Development of broad-spectrum antibiofilm drugs: strategies and challenges. Dharmaprakash A; Thandavarayan R; Joseph I; Thomas S Future Microbiol; 2015; 10(6):1035-48. PubMed ID: 26059624 [TBL] [Abstract][Full Text] [Related]
38. GAIN Act legislation: is it enough? Tillotson GS Lancet Infect Dis; 2012 Nov; 12(11):823-4. PubMed ID: 23099071 [No Abstract] [Full Text] [Related]
39. Postgenomic strategies in antibacterial drug discovery. Brötz-Oesterhelt H; Sass P Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial drug discovery: lessons of history and future strategies. Travis A; Chernova O; Chernov V; Aminov R Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]